Cargando…
Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease
Transplantation of mesenchymal stem cells (MSCs) in the setting of cardiovascular disease, such as heart failure, cardiomyopathy and ischemic heart disease, has been associated with good clinical outcomes in several trials. A reduction in left ventricular remodeling, myocardial fibrosis and scar siz...
Autores principales: | Matta, Anthony, Nader, Vanessa, Lebrin, Marine, Gross, Fabian, Prats, Anne-Catherine, Cussac, Daniel, Galinier, Michel, Roncalli, Jerome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140025/ https://www.ncbi.nlm.nih.gov/pubmed/35626657 http://dx.doi.org/10.3390/cells11101620 |
Ejemplares similares
-
Transplantation of CD34+ cells for myocardial ischemia
por: Matta, Anthony, et al.
Publicado: (2021) -
Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy
por: Razeghian-Jahromi, Iman, et al.
Publicado: (2021) -
Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience
por: Nader, Vanessa, et al.
Publicado: (2021) -
Benefits of Interventional Telemonitoring on Survival and Unplanned Hospitalization in Patients With Chronic Heart Failure
por: Galinier, Michel, et al.
Publicado: (2022) -
Mortality rate after coronary revascularization in heart failure patients with coronary artery disease
por: Nader, Vanessa, et al.
Publicado: (2023)